1887

Journal of Medical Microbiology logo

Volume 67, Issue 4

The protective effect and diagnostic performance of NOX-5 in Crimean–Congo haemorrhagic fever patients Free

Abstract

Crimean-Congo haemorrhagic fever (CCHF) is an acute viral haemorrhagic disease. Reactive oxygen species that are mainly generated by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) enzyme family have a pivotal role in the pathophysiology of many diseases. The serum levels of NOX isoforms in patients with CCHF have yet to be assessed.

This prospective study was conducted at Cumhuriyet University, Turkey. Only patients with CCHF confirmed by the National Reference Virology Laboratory were enrolled in the study. The study subjects comprised 67 CCHF patients and 70 healthy control subjects. The quantitative sandwich ELISA technique was used for the determination of serum NOX 1, 2, 4 and 5.

Higher median median NOX-1 (=0.001) and NOX-5 (<0.001) levels were found in patients compared to the control group. Higher median serum NOX-5 levels were found in the low-grade disease group compared to the intermediate–high disease group according to two different severity scores (=0.003). Negative correlations were also found between the serum NOX-5 levels and the severity scores [(<0.05, =−0.259), (<0.01, =−0.417)]. The area under the curve (AUC) values for the NOX-1 and NOX-5 were 0.67 (confidence interval: 0.58–0.75) and 0.99 (confidence interval: 0.95–1.00), respectively. Lower NOX-5 levels were found in patients receiving thrombocyte suspension (=0.004)

NOX-5 may have a protective effect on CCHF patients and the measurement of serum NOX-5 levels may be used as a novel biochemical test in the diagnosis of CCHF.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): CCHF , NADPH oxidase , NOX-1 and NOX-5
© 2018 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000712
2018-04-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/4/543.html?itemId=/content/journal/jmm/10.1099/jmm.0.000712&mimeType=html&fmt=ahah

References

  1. Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z et al. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-a multi-center cross-sectional survey in Eurasia. PLoS One 2017; 12:e0182315 [View Article][PubMed]
     [Google Scholar]
  2. Büyüktuna SA, Doğan HO, Bakır D, Erşan S, Koç D et al. Increased irisin concentrations in patients with Crimean-Congo hemorrhagic fever. Jpn J Infect Dis 2017; 70:475–478 [View Article][PubMed]
     [Google Scholar]
  3. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004; 64:145–160 [View Article][PubMed]
     [Google Scholar]
  4. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10:1379–1384 [View Article][PubMed]
     [Google Scholar]
  5. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11:S794–S800 [View Article][PubMed]
     [Google Scholar]
  6. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res 2013; 100:159–189 [View Article][PubMed]
     [Google Scholar]
  7. Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis 2011; 3:285 [View Article][PubMed]
     [Google Scholar]
  8. Sirker A, Zhang M, Shah AM. NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res Cardiol 2011; 106:735–747 [View Article][PubMed]
     [Google Scholar]
  9. Drummond GR, Sobey CG. Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol Metab 2014; 25:452–463 [View Article][PubMed]
     [Google Scholar]
  10. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4:181–189 [View Article][PubMed]
     [Google Scholar]
  11. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87:245–313 [View Article][PubMed]
     [Google Scholar]
  12. Lassègue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010; 30:653–661 [View Article][PubMed]
     [Google Scholar]
  13. Bureau C, Bernad J, Chaouche N, Orfila C, Béraud M et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001; 276:23077–23083 [View Article][PubMed]
     [Google Scholar]
  14. de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology 2010; 52:47–59 [View Article][PubMed]
     [Google Scholar]
  15. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol 2009; 83:12934–12946 [View Article][PubMed]
     [Google Scholar]
  16. Vlahos R, Stambas J, Bozinovski S, Broughton BR, Drummond GR et al. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog 2011; 7:e1001271 [View Article][PubMed]
     [Google Scholar]
  17. Bakır M, Gözel MG, Köksal I, Aşık Z, Günal Ö et al. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis 2015; 34:325–330 [View Article][PubMed]
     [Google Scholar]
  18. Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN et al. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 2013; 57:1270–1274 [View Article][PubMed]
     [Google Scholar]
  19. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R et al. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 2012; 12:805–811 [View Article][PubMed]
     [Google Scholar]
  20. Hernandes MS, D'Avila JC, Trevelin SC, Reis PA, Kinjo ER et al. The role of Nox2-derived ROS in the development of cognitive impairment after sepsis. J Neuroinflammation 2014; 11:36 [View Article][PubMed]
     [Google Scholar]
  21. Hofstetter AR, de La Cruz JA, Cao W, Patel J, Belser JA et al. NADPH Oxidase 1 is associated with altered host survival and T cell phenotypes after influenza A virus infection in mice. PLoS One 2016; 11:e0149864 [View Article][PubMed]
     [Google Scholar]
  22. Tütüncü EE, Gurbuz Y, Ozturk B, Kuscu F, Sencan I. Serum nitric oxide levels in patients with Crimean-Congo haemorrhagic fever. Scand J Infect Dis 2010; 42:385–388 [View Article][PubMed]
     [Google Scholar]
  23. Karadag-Oncel E, Erel O, Ozsurekci Y, Caglayik DY, Kaya A et al. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever. Jpn J Infect Dis 2014; 67:22–26 [View Article][PubMed]
     [Google Scholar]
  24. Tufan ZK, Hasanoglu I, Kolgelier S, Alisik M, Ergin M et al. A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever. Redox Rep 2017; 22:241–245 [View Article][PubMed]
     [Google Scholar]
  25. Bartimoccia S, Carnevale R, Sanguigni V, de Falco E, Frati G et al. NOX 5 is expressed in platelets from patients with chronic granulomatous disease. Thromb Haemost 2016; 116:198–200 [View Article][PubMed]
     [Google Scholar]
  26. Seno T, Inoue N, Gao D, Okuda M, Sumi Y et al. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 2001; 103:399–409 [View Article][PubMed]
     [Google Scholar]
  27. Krötz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24:1988–1996 [View Article][PubMed]
     [Google Scholar]
  28. Krötz F, Sohn HY, Gloe T, Zahler S, Riexinger T et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002; 100:917–924 [View Article][PubMed]
     [Google Scholar]
  29. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis 2014; 8:e2858 [View Article][PubMed]
     [Google Scholar]
  30. Kim HJ, Kim CH, Ryu JH, Kim MJ, Park CY et al. Reactive oxygen species induce antiviral innate immune response through IFN-λ regulation in human nasal epithelial cells. Am J Respir Cell Mol Biol 2013; 49:855–865 [View Article][PubMed]
     [Google Scholar]
  31. Olagnier D, Peri S, Steel C, van Montfoort N, Chiang C et al. Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathog 2014; 10:e1004566 [View Article][PubMed]
     [Google Scholar]
  32. Vanhomwegen J, Alves MJ, Zupanc TA, Bino S, Chinikar S et al. Diagnostic assays for Crimean-Congo hemorrhagic fever. Emerg Infect Dis 2012; 18:1958–1965 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000712
Loading
The protective effect and diagnostic performance of NOX-5 in Crimean–Congo haemorrhagic fever patients
J. Med. Microbiol. 67, 543 (2018); https://doi.org/10.1099/jmm.0.000712
/content/journal/jmm/10.1099/jmm.0.000712
/content/journal/jmm/10.1099/jmm.0.000712
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error